NASDAQ
Total Transactions
52
14 buys /38 sells
Shares Acquired
5,130,042
Transactions: 14•Avg: 366,431.57
Shares Disposed
77,262,217
Transactions: 38•Avg: 2,033,216.24
Net Activity
-72,132,175
Net Selling•Ratio: 36.84%
Q4 2025(Current) | 5,130,042 | 77,262,217 | -72,132,175 | 36.84% |
Q3 2025 | 3,260,262 | 2,367,562 | +892,700 | 125.00% |
Q2 2025 | 1,070,996 | 148,953 | +922,043 | 1100.00% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 72,132,175 shares•Acquired/Disposed Ratio: 36.84%
Net Activity | |||||
|---|---|---|---|---|---|
BCW Bernard Christopher Whitten | Director, officer: see remarks | 5 | 370,000 | 14,818,540 | -14,448,540 |
MC MEANWELL CLIVE | Director, officer: executive chairman | 5 | 37,625 | 13,097,619 | -13,059,994 |
VHL Validae Health, L.P. | 10 percent owner | 1 | 0 | 12,767,462 | -12,767,462 |
PHPGL Population Health Partners GP, LLC | 10 percent owner | 1 | 0 | 12,639,787 | -12,639,787 |
BK Burow Kristina | Director | 5 | 18,813 | 8,478,758 | -8,459,945 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-11-13 | 10 percent owner, other: see remark 1 | Sale | 2,230,450 | $0 | $22.3 | - | |
2025-11-13 | Director, 10 percent owner: | Sale | 8,313,680 | $0 | $83.14 | - | |
2025-11-13 | Officer: chief medical officer | Purchase | 17,000 | $0 | $0 | 17,000 | |
2025-11-13 | Officer: chief medical officer | Sale | 17,000 | $0 | $0.17 | - | |
2025-11-13 | Officer: chief medical officer | Sale | 120,000 | $29.25 | $3,510,000 | - |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
FL FMR LLC | 10 percent owner, other: see remark 1 | Nov 17, 2025 | |
AVPXL ARCH Venture Partners XII, LLC | Director, 10 percent owner: | Nov 14, 2025 | |
MS Marso Steven | Officer: chief medical officer | Nov 13, 2025 | |
MS Marso Steven | Officer: chief medical officer | Nov 13, 2025 | |
MS Marso Steven | Officer: chief medical officer | Nov 13, 2025 |
Net change in shares shown on right
No price data available for this timeframe.